Skip to main contentSkip to navigation
Sirius Investors
RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZB
NASDAQ•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for RYZB. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
941.27M
-2.71% over period
CAGR: -1.36%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
822.68M
-0.22% over period
CAGR: -0.11%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Sep 30, 2023

EV/EBITDA

Distorted

-5.63x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-118.59M

EV is -12.6% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: +2.2 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 13.69x

Share count change in dataset: -2.71%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 2022941.27M822.68M$24.0039.22M
Dec 31, 2021967.46M925.95M$24.0040.31M
Dec 31, 2020967.46M824.49M$24.0040.31M

Enterprise Value Analysis

Price Change (Dec 2021 to Dec 2022)

The stock price has decreased from Dec 2021 to Dec 2022.
0.00%

Recent Volatility

The stock price has been relatively stable over the last 3 periods, indicating a lower risk profile.
0.00

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.00

Market Cap Change (Dec 2021 to Dec 2022)

The company's market capitalization has decreased from Dec 2021 to Dec 2022.
-2.71%

Enterprise Value Change (Dec 2021 to Dec 2022)

The company's enterprise value has decreased from Dec 2021 to Dec 2022, suggesting a decline in the company's total economic value.
-11.15%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
-1.36%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
-0.11%